1100
|
Vaxchora
|
Cholera
|
Vibrio cholerae
|
Live attenuated
|
Emergent Travel Health Inc.
|
Approved
|
Oral
|
NA
|
NA
|
1101
|
Dukoral
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
SBL Vaccines
|
Approved
|
Oral
|
31879125
|
NA
|
1102
|
Shanchol
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
Shantha Biotechnics Limited
|
Approved
|
Oral
|
NA
|
NA
|
1103
|
Euvichol
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
EuBiologics Co., Ltd.
|
Approved
|
Oral
|
31879125
|
NA
|
1104
|
Euvichol-plus
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
EuBiologics Co., Ltd.
|
Approved
|
Oral
|
31879125
|
NA
|
1105
|
mORC-Vax
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
Vabiotech, Hanoi
|
Approved
|
Oral
|
31879125
|
NA
|
1106
|
ORC-Vax
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
Vabiotech, Hanoi
|
Approved
|
Oral
|
21498389
|
NA
|
1318
|
PXVX0200
|
Cholera
|
Vibrio cholerae
|
Live attenuated
|
Emergent BioSolutions
|
Clinical - Phase 3
|
Oral
|
21498389
|
NCT01895855
|
1319
|
Cholvax
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
International Centre for Diarrhoeal Disease Research, Bangladesh
|
Clinical - Phase 2
|
Oral
|
31879125
|
NCT02742558
|
1320
|
Oral Cholera vaccine (in Vietnam)
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
International Vaccine Institute
|
Clinical - Phase 2
|
Oral
|
NA
|
NCT00128011
|
1321
|
Choleragarde
|
Cholera
|
Vibrio cholerae
|
Live attenuated
|
International Vaccine Institute
|
Clinical - Phase 2
|
Oral
|
NA
|
NCT00741637
|
1322
|
VLA1701
|
Cholera
|
Vibrio cholerae
|
NA
|
Valneva Austria GmbH
|
Clinical - Phase 2
|
Oral
|
NA
|
NCT03576183
|
1323
|
HL-OCV
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
International Centre for Diarrhoeal Disease Research
|
Clinical - Phase 1, Phase 2
|
Oral
|
NA
|
NCT02823899
|
1324
|
Peru-15-pCTB
|
Cholera
|
Vibrio cholerae
|
Live attenuated
|
National Institute of Allergy and Infectious Diseases (NIAID)
|
Clinical - Phase 1
|
Oral
|
NA
|
NCT00654108
|